REHOVOT, Israel and NEW BRUNSWICK, N.J., May 1 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (Nasdaq: ROSG) announced that the company will report first quarter 2007 financial results on Tuesday, May 8, 2007, after U.S. financial markets close. Following the announcement, senior management will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss financial results and corporate highlights. To access the live conference on May 8 at 4:30 p.m. Eastern Time via phone, please dial (866)-409-1557 from the United States and Canada or 1-(913)-312-1237 internationally. The conference passcode is 3026948. Please dial in approximately fifteen minutes prior to the start of the call. A telephone replay will be available beginning approximately one hour after the call through May 15 and may be accessed by dialing (888)-203-1112 from the United States and Canada or 1-(719)-457-0820 internationally. The replay passcode is 3026948. To access the live and subsequently archived webcast of the conference call, go to the Investor Relations section of the Company's website at http://www.rosettagenomics.com. Please connect to the web site at least 15 minutes prior to the call to allow for any software download that may be necessary. About Rosetta Genomics Rosetta Genomics (Nasdaq: ROSG) is a leader in the development of microRNA-based diagnostics and therapeutics. The company's integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong IP position and strategic alliances with leading biotechnology companies, Rosetta Genomics is working to develop a full range of diagnostic and therapeutic products based on microRNAs. The company's primary focus is in the development of microRNA-based products to diagnose and treat different forms of cancer and infectious diseases. Media and Investors Ron Kamienchick, 972-8-948-4785 Ron_ka@rosettagenomics.com
SOURCE Rosetta Genomics, Ltd.